Cutaneous gamma/delta T-cell lymphoma during treatment with etanercept for rheumatoid arthritis

Acta Dermato-Venereologica

Volumn 89, Issue 6, 2009, Pages 653-654

  Koens, Lianne ^a   Senff, Nancy J ^a   Vermeer, Maarten H ^a   Ronday, H Karel ^b   Willemze, Rein ^a   Jansen, Patty M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HAGA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; ETANERCEPT; METHOTREXATE;

AGED; ANAMNESIS; CASE REPORT; DRUG DOSE INCREASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN DEFECT; SKIN LYMPHOMA; T CELL DELTA; T CELL GAMMA; T CELL LYMPHOMA; T LYMPHOCYTE;

AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOPSY; HUMANS; IMMUNOGLOBULIN G; LYMPHOMA, T-CELL, CUTANEOUS; MALE; RECEPTORS, TUMOR NECROSIS FACTOR; SKIN; SKIN NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 71949083421     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0728     Document Type: Letter

References (17)

1. Valesini G, Iannuccelli C, Marocchi E, Pascoli L, Scalzi V, Di Franco M. Biological and clinical effects of anti-TNFalpha treatment. Autoimmun Rev 2007; 7: 35-41. (Pubitemid 47633389)
2. Brown SL, Greene MH, Gershon SK, Edwards ET, Braun MM. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum 2002; 46: 3151-3158.
3. Lourari S, Prey S, Livideanu C, Jamard B, Lamant L, Cantagrel A, et al. Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-α blocking agents: two cases. J Eur Acad Dermatol Venereol 2009; 23: 967-968.
4. Mahe E, Descamps V, Grossin M, Fraitag S, Crickx B. CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab. Br J Dermatol 2003; 149: 170-173. (Pubitemid 36966529)
5. Adams AE, Zwicker J, Curiel C, Kadin ME, Falchuk KR, Drews R, et al. Aggressive cutaneous T-cell lymphomas after TNF-alpha blockade. J Am Acad Dermatol 2004; 51: 660-662. (Pubitemid 39278092)
6. Michot C, Costes V, Gerard-Dran D, Guillot B, Combes B, Dereure O. Subcutaneous panniculitis-like T-cell lymphoma in a patient receiving etanercept for rheumatoid arthritis. Br J Dermatol 2009; 160: 889-890.
7. Dauendorffer JN, Rivet J, Allard A, Bachelez H. Sezary syndrome in a patient receiving infliximab for ankylosing spondylitis. Br J Dermatol 2007; 156: 742-743. (Pubitemid 46452346)
8. Sanli H, Ataman S, Akay BN, Yilmaz A, Yildizlar D, Gürgey E. Mycosis fungoides in a patient with ankylosing spondylitis during infliximab therapy. J Drugs Dermatol 2007; 6: 834-836.
9. Dalle S, Balme B, Berger F, Hayette S, Thomas L. Mycosis fungoides-associated follicular mucinosis under adalimumab. Br J Dermatol 2005; 153: 207-208 (Pubitemid 41044554)
10. Bucher C, Degen L, Dirnhofer S, Pless M, Herrmann R, Schraml P, et al. Biologics in inflammatory disease: infliximab associated risk of lymphoma development. Gut 2005; 54: 732-733. (Pubitemid 40559270)
11. Lafaille P, Bouffard D, Provost N. Exacerbation of undiagnosed mycosis fungoides during treatment with etanercept. Arch Dermatol 2009; 145: 94-95.
12. Gaulard P, Berti E, Willemze R, Jaffe ES. Primary cutaneous peripheral T-cell lymphomas, rare subtypes. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al, editors. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008, p. 302-303.
13. Jaffe ES, Ralfkiaer E. Subcutaneous panniculitis-like T-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization classification of tumours. Pathology and tumours of haematopoietic and lymphoid tissue. Lyon: IARC Press; 2001, p. 212-213.
14. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90: 354-371. (Pubitemid 27276581)
15. Willemze R, Jansen P, Cerroni L, Berti E, Santucci M, Assaf C, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification and prognostic factors. An EORTC cutaneous lymphoma group study of 83 cases. Blood 2008; 111: 838-845.
16. Wolfe F, Michaud K. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation. Arthritis Rheum 2007; 56: 1433-1439. (Pubitemid 46764070)
17. Beyer M, Steinhoff M, Anagnostopoulos I, Assaf C, Sterry W. Hepatosplenic T-cell lymphomas and therapy with TNF-α-blocking biologics: a risk for psoriasis patients? J Dtsch Dermatol Ges 2009; 7: 191-194.